Harrow (HROW) Accounts Payables (2010 - 2026)
Harrow (HROW) posted quarterly Accounts Payables of $30.0 million for Q1 2026, down 19.08% year-over-year from $37.1 million in Q1 2025, and down 15.1% quarter-over-quarter from $35.4 million in Q4 2025.
Harrow (HROW) Accounts Payables (2010 - 2026) Analysis & Trends
Harrow's Accounts Payables history runs 17 years deep, the most recent figure standing at $30.0 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 19.08% year-over-year to $30.0 million; the TTM figure through Mar 2026 stood at $30.0 million (down 19.08% YoY), while the FY2025 annual figure was $35.4 million, down 8.79% from the prior year.
- Accounts Payables for Q1 2026 stood at $30.0 million, down from $35.4 million in the prior quarter.
- The five-year high for Accounts Payables was $38.8 million in Q4 2024, with the low at $6.8 million in Q1 2022.
- The 5-year median for Accounts Payables is $20.2 million (2025), against an average of $21.3 million.
- Peak annual rise in Accounts Payables reached 145.19% in 2025, while the deepest fall reached 20.24% in 2025.
- Harrow's Accounts Payables stood at $13.8 million in 2022, then soared by 78.5% to $24.6 million in 2023, then surged by 57.69% to $38.8 million in 2024, then retreated by 8.79% to $35.4 million in 2025, then retreated by 15.1% to $30.0 million in 2026.
- Business Quant data shows HROW's Accounts Payables at $30.0 million in Q1 2026, $35.4 million in Q4 2025, and $20.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Harrow | 1.58 Bn | 1.49 Bn | 50.36 Mn | 34.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.06 Mn |
| Mar 31, 2026 | 30.02 Mn |
| Dec 31, 2025 | 35.36 Mn |
| Sep 30, 2025 | 20.16 Mn |
| Jun 30, 2025 | 25.41 Mn |
| Mar 31, 2025 | 37.10 Mn |
| Dec 31, 2024 | 38.76 Mn |
| Sep 30, 2024 | 25.28 Mn |
| Jun 30, 2024 | 22.26 Mn |
| Mar 31, 2024 | 15.13 Mn |
| Dec 31, 2023 | 24.58 Mn |
| Sep 30, 2023 | 12.77 Mn |
| Jun 30, 2023 | 17.82 Mn |
| Mar 31, 2023 | 13.79 Mn |
| Dec 31, 2022 | 13.77 Mn |
| Sep 30, 2022 | 14.11 Mn |
| Jun 30, 2022 | 9.20 Mn |
| Mar 31, 2022 | 6.76 Mn |
| Dec 31, 2021 | 6.34 Mn |
| Sep 30, 2021 | 7.34 Mn |